Teva Pharmaceutical (TEVA) Enters Into a License Agreement With Prestige Biopharma for the Commercialization of Tuznue in Europe

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best affordable stocks to buy under $20. Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Limited (NYSE:TEVA), announced on October 20 that it entered into a license agreement with Prestige Biopharma for “the commercialization of Tuznue (trastuzumab), a biosimilar to Herceptin” across a majority of European markets. Teva Pharmaceutical Industries Limited (TEVA): Among Small-Cap Healthcare Stocks Hedge F ...